Cargando…

An efficient piecewise linear model for predicting activity of caspase-3 inhibitors

BACKGROUND AND PURPOSE OF THE STUDY: Multimodal distribution of descriptors makes it more difficult to fit a single global model to model the entire data set in quantitative structure activity relationship (QSAR) studies. METHODS: The linear (Multiple linear regression; MLR), non-linear (Artificial...

Descripción completa

Detalles Bibliográficos
Autores principales: Firoozpour, Loghman, Sadatnezhad, Khadijeh, Dehghani, Sholeh, Pourbasheer, Eslam, Foroumadi, Alireza, Shafiee, Abbas, Amanlou, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556068/
https://www.ncbi.nlm.nih.gov/pubmed/23351435
http://dx.doi.org/10.1186/2008-2231-20-31
Descripción
Sumario:BACKGROUND AND PURPOSE OF THE STUDY: Multimodal distribution of descriptors makes it more difficult to fit a single global model to model the entire data set in quantitative structure activity relationship (QSAR) studies. METHODS: The linear (Multiple linear regression; MLR), non-linear (Artificial neural network; ANN), and an approach based on “Extended Classifier System in Function approximation” (XCSF) were applied herein to model the biological activity of 658 caspase-3 inhibitors. RESULTS: Various kinds of molecular descriptors were calculated to represent the molecular structures of the compounds. The original data set was partitioned into the training and test sets by the K-means classification method. Prediction error on the test data set indicated that the XCSF as a local model estimates caspase-3 inhibition activity, better than the global models such as MLR and ANN. The atom-centered fragment type CR(2)X(2), electronegativity, polarizability, and atomic radius and also the lipophilicity of the molecule, were the main independent factors contributing to the caspase-3 inhibition activity. CONCLUSIONS: The results of this study may be exploited for further design of novel caspase-3 inhibitors.